Receptor Mechanism: GHRH Pathway vs Dual Agonism
CJC-1295 no DAC binds to GHRH receptors on anterior pituitary somatotrophs, triggering cAMP-mediated signaling that releases GH from intracellular vesicles. The 'no DAC' modification. Removal of the lysine residue that would otherwise bind albumin. Prevents th
This comparison does not assign a generated winner or score.
- CJC-1295 no DAC binds to GHRH receptors on anterior pituitary somatotrophs, triggering cAMP-mediated signaling that releases GH from intracellular vesicles. The 'no DAC' modification. Removal of the lysine residue that would otherwise bind albumin. Prevents the extended serum retention seen in CJC-1295 with DAC, keeping the half-life under 30 minutes. This short window matches the body's natural GH pulse intervals (every 3–5 hours), allowing the peptide to enhance existing pulses without creating sustained supraphysiological receptor occupancy.
- Ipamorelin acts on ghrelin receptors (growth hormone secretagogue receptors, GHSR-1a), a distinct G-protein coupled receptor system that also converges on somatotroph activation but through a separate intracellular cascade. Ghrelin receptor stimulation bypasses GHRH entirely. It works even when GHRH signaling is pharmacologically blocked. The combination protocol therefore activates two independent pathways simultaneously: GHRH receptor enhancement via CJC-1295 and ghrelin receptor activation via Ipamorelin. In vitro studies on isolated pituitary cells demonstrate non-competitive receptor binding, meaning the two peptides don't interfere with each other's efficacy.
- The practical outcome: when administered together, CJC-1295 extends the duration of each endogenous GH pulse while Ipamorelin initiates additional pulses. A monotherapy protocol might produce 3–4 enhanced GH peaks per day aligned with the subject's circadian rhythm. The combination can generate 5–7 peaks, with each pulse showing higher amplitude and longer decay time. Research examining pulsatile vs steady-state GH exposure effects must account for this architectural difference.